4//SEC Filing
Stancic Ana 4
Accession 0000930413-12-000226
CIK 0000727510other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:44 PM ET
Size
7.7 KB
Accession
0000930413-12-000226
Insider Transaction Report
Form 4
Stancic Ana
Senior VP, Finance and CFO
Transactions
- Disposition to Issuer
Common Stock
2012-01-17−45,000→ 15,000 total - Award
Common Stock
2012-01-17+45,000→ 70,000 total
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The two reported transactions involved an amendment of an outstanding RSU grant, resulting in the deemed cancellation of the "old" RSUs and the making of a replacement RSU grant. The RSU grant was originally made on November 17, 2011, and provided that the RSUs would vest in full on November 17, 2014, if the Reporting Person remained employed by the Issuer on such date; provided, however, that the vesting of 50% of the RSUs was to be accelerated upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer. On January 17, 2012, the RSU grant was amended to provide that the RSUs will vest in three (3) tranches. Of the 45,000 RSUs granted, 15,000 RSUs will vest on each of November 17, 2012, November 17, 2013 and November 17, 2014, in each case if the Reporting Person remains employed by the Issuer on such date.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001320271
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 6:44 PM ET
- Size
- 7.7 KB